Severe bacterial infections of the skin: Uncommon presentations

Clinics in Dermatology

Volumn 23, Issue 6, 2005, Pages 621-629

  Marina, Sonya S ^a   Bocheva, Georgeta S ^a   Kazanjieva, Jana S ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTHRAX VACCINE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; CORTICOSTEROID; DICLOXACILLIN; DOXYCYCLINE; FLUCLOXACILLIN; GLOBULIN; IMMUNOGLOBULIN G; MINOCYCLINE; NAFCILLIN; OXACILLIN; PENICILLIN G; PENICILLIN V; PROCAINE PENICILLIN; RIFAMPICIN; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

ANTHRAX; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BURN; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; IMMUNE STATUS; INTENSIVE CARE; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RECALCITRANT ERYTHEMATOUS DESQUAMATING DISORDER; SKIN INFECTION; STAPHYLOCOCCUS; STREPTOCOCCUS; TOXIC EPIDERMAL NECROLYSIS; TOXIC SHOCK SYNDROME;

ADULT; AGE DISTRIBUTION; AGED; ANTHRAX; ANTI-BACTERIAL AGENTS; BULGARIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 28644437963     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2005.07.003     Document Type: Article

References (84)

1. L.A. Drage Life-threatening rashes: dermatologic signs of four infectious diseases Mayo Clin Proc 74 1999 68 72
2. P.M. Schlievert, K.N. Shands, and B.B. Dan Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome J Infect Dis 143 1981 509
3. M.S. Bergdoll, B. Crass, and R.F. Reiser A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock syndrome. Staphylococcus aureus isolates Lancet 1 1981 1017
4. J.E. Alouf, and H. Muller-Alouf Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects Int J Med Microbiol 292 2003 429 440
5. K.R. Acharya, E.F. Passalacqua, and E.Y. Jones Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1 Nature 367 1994 94 97
6. S.M. Manders Toxin-mediated streptococcal and staphylococcal disease J Am Acad Dermatol 39 1998 383 398
7. J. Todd, M. Fishaut, F. Kapral, and T. Welch Toxic-shock syndrome associated with phage-group I staphylococci Lancet 2 1978 116 118
8. J.P. Davis, P.J. Chesney, and P.J. Wand Toxic-shock syndrome N Engl J Med 303 1980 1429
9. E.H. Kass, and J. Parsonnet On the pathogenesis of the toxic shock syndrome Rev Infect Dis 9 1987 S482 S489
10. M.T. Osterholm, J.P. Davis, and R.W. Gipson Tre-state toxic-shock syndrome study. I. Epidemiologic findings J Infect Dis 1982 145 431
11. J.P. Davis, M.T. Osterholm, and C.M. Helms Tre-state toxic-shock syndrome study. II. Clinical and laboratory fundings J Infect Dis 145 1982 441
12. P.M. Schlievert Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin J Infect Dis 172 1995 1112 1114
13. A.L. Reingold, N.T. Hargrett, and B.B. Dan Nonmenstrual toxic shock syndrome. A review of 130 cases Ann Intern Med 96 1982 871 874
14. K.C. Kain, M. Schulzer, and A.W. Chow Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariante discriminant analyses Clin Infect Dis 16 1993 100
15. C.J. Fisher, B.Z. Horowitz, and S.M. Nolan The clinical spectrum of toxic shock syndrome West J Med 135 1981 175 182
16. P.J. Chesney, M.S. Bergdoll, J.P. Davis, and J.M. Vergeront The disease spectrum, epidemiology, and etiology of toxic-shock syndrome Annu Rev Microbiol 38 1984 315 338
17. M. Andrews, E.M. Parent, M. Barry, and J. Parsonnet Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment Clin Infect Dis 32 2001 1470 1479
18. A.L. Paris, D.R. Herwaldt, and D. Blum Pathologic findings in twelve fatal cases of toxic shock syndrome Ann Intern Med 96 1982 852
19. M. Kadurina, G. Bocheva, and St. Tonev Penicillin and semisynthetic penicillins in dermatology Clin Dermatol 21 2003 12 23
20. N.E. Russel, and R.E. Pachorek Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndrome Ann Pharmacother 34 2000 936 939
21. L.A. Cone, D.R. Woodard, and R.C. Byrd A recalcitrant erythematous desquamating disorder associated with toxin-producing staphylococci in patients with AIDS J Infect Dis 165 1992 638 643
22. A. Verbon, and C.J. Fisher Severe recalcitrant erythematous desquamating disorder with fatal recurrent toxic shock syndrome in a patient without AIDS Clin Infect Dis 24 1997 1274 1275
23. Y. Sarai, H. Nakahara, T. Ishikawa, I. Kondo, and S. Futaki A bacteriological study on children with staphylococcal toxic epidermal necrolysis in Japan Dermatologica 154 1977 161 167
24. A.S. Dajani The scalded skin syndrome: relation to phage group II staphylococci J Infect Dis 125 1972 548
25. M.E. Melish, and L.A. Glasgow The staphylococcal scalded skin syndrome N Engl J Med 282 1970 1114 1119
26. G.K. Patel, and A.Y. Finley Staphylococcal scalded skin syndrome. Diagnosis and management Am J Clin Dermatol 4 2003 165 175
27. M. Amagai, N. Matsuyoshi, and Z.H. Wang Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein 1 Nat Med 6 2000 1275 1277
28. Y. Hanakawa, N.M. Schechter, and C. Lin Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome J Clin Invest 110 2002 53 60
29. G. Levine, and C.W. Norden Staphylococcal scalded skin syndrome in an adult N Engl J Med 28 1972 1339 1340
30. G.K. Patel, S. Varma, and A.Y. Finley Staphylococcal scalded skin syndrome in healthy adults Br J Dermatol 142 2000 1253 1255
31. Oyakes, T. Oh-I, and M. Koga Staphylococcal scalded skin syndrome in a healthy adult J Dermatol 28 2001 145 148
32. G. Ritter von Rittershain The exfoliativa dermatitis jüngerer Säulinge Centralz Kinderheik 2 1878 3 23
33. W.A. Gillespie, R.C. Pope, and K. Simpson Pemphigus neonatorum caused by Staphylococcus aureus type 71 BMJ 5026 1957 1044 1046
34. A. Lyell Toxic epidermal necrolysis: an eruption resembling scalding of the skin Br J Dermatol 68 1956 355 361
35. M.E. Melish, L.A. Glasgow, and M.D. Turner Staphylococcal scalded skin syndrome: isolation and partial characterization of the exfoliative toxin J Infect Dis 125 1972 129 140
36. P.M. Elias, P. Fritsch, and H. Mittermayer Experimental staphylococcal toxic epidermal necrolysis (TEN) in adult humans and mice J Lab Clin Med 84 1974 414 424
37. F.A. Kapral, and M.M. Miller Product of Staphylococcus aureus responsible for the scalded skin syndrome Infect Immun 4 1971 541 545
38. A. Lyell The staphylococcal scalded skin syndrome a historical perspective: emergence of dermopathic strains of Staphylococcus aureus and the discovery of the epidermolytic toxin J Am Acad Dermatol 9 1983 285 294
39. S.D. Resnick Staphylococcal toxin mediated syndroma in childhood Semin Dermatol 11 1992 11 18
40. C. Moss, and E. Gupta The Nikolsky sign in staphylococcal scalded skin syndrome Arch Dis Child 79 1998 290
41. R. Suzuku, S. Iwasaki, and Y. Ito Adult staphylococcal scalded skin syndrome in a peritoneal dialysis patients Clin Exp Nephrol 7 2003 77 80
42. P. Petzelbauer, K. Konrad, and K. Wolff Staphylococcal scalded skin syndrome in 2 adults with acute kidney failure Hautarzt 40 1989 90 93
43. P.M. Elias, P. Fritsch, and E.V. Epstein Staphylococcal scalded skin syndrome: clinical features, pathogenesis, and recent microbiological and biochemical development Arch Dermatol 113 1977 207 219
44. P.M. Elias, and S.W. Levy Bullous impetigo: occurrence of scalded skin syndrome in an adult Arch Dermatol 11 1976 856 858
45. R.S. Machang'u, G. Mgode, and N. Gisakanyi Recurrent staphylococcal scalded skin syndrome in children: report of two cases East Afr Med J 74 1997 603 604
46. Ed. Shelley, W.B. Shelley, and N.Y. Talanin Chronic staphylococcal scalded skin syndrome Br J Dermatol 139 1998 319 324
47. P.I. Rudolph, W. Schwartz, and J.J. Leyden Treatment of staphylococcal toxic epidermal necrolysis Arch Dermatol 110 1974 559 562
48. M.E. Melish, and L.A. Glasgow The staphylococcal scalded skin syndrome: the expanded clinical syndrome J Paediatr 78 1971 958 967
49. S. Yokota, T. Imagawa, and S. Katakura Staphylococcal scalded skin syndrome caused by exfoliative toxin B producing methicillin resistant Staphylococcus aureus [letter] Eur J Pediatr 155 1996 722
50. K.M. Acland, A. Darvay, and C. Griffin Staphylococcal scalded skin syndrome in an adult associated with methicillin resistant Staphylococcus aureus Br J Dermatol 140 1999 518 520
51. Y. Ito, M. Funabashiyoh, and K. Toda Staphylococcal scalded skin syndrome in an adult due to methicillin resistant Staphylococcus aureus Clin Exp Nephrol 7 2003 77 80
52. A.V. Starikov Experience in using extracorporeal detoxication in the intensive therapy of autoimmune pathology Lik Sprava 9-12 1995 155 157
53. B.B. Wiley, S. Allman, and M. Rogolsky Staphylococcal scalded skin syndrome: potentiation by immunosuppression in mice; toxin mediated exfoliation in a healthy adult Infect Immun 9 1974 636 640
54. E.L. Barsumian, P.M. Schlievert, and D.W. Watson Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins Infect Immun 22 1978 681 688
55. T. Proft, and S.L. Moffatt Identification and characterization of novel superantigens from Streptococcus pyogenes J Exp Med 189 1999 89 102
56. T. Proft, and S.L. Moffatt The streptococcal superantigen SMEZ exhibit wide allelic variation, mosaic structure, and significant antigenic variation J Exp Med 191 2000 1765 1776
57. J.K. McCormick, A.A. Pragman, and J.C. Stolpa Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen Infect Immun 69 2001 1381 1388
58. M. Kotb Bacterial pyrogenic exotoxins as superantigens Clin Microbiol Rev 8 1995 411 426
59. D.L. Stevens, A.E. Bryant, and S.P. Hackett Group A streptococcal bacteriemia: the role of tumor necrosis factor in shock and organ failure J Infect Dis 173 1996 619 626
60. D.L. Stevens Streptococcal toxic shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment Emerg Infect Dis 1 1995 69 78
61. D.L. Stevens The toxins of group A streptococcus, the flesh eating bacteria Immunol Invest 26 1997 129 150
62. D.L. Stevens Streptococcal toxic shock syndrome Clin Microbiol Infect 8 2002 133 136
63. M. Sharma, R. Khatib, and M. Fakih Clinical characteristics of necrotizing fasciitis caused by group G streptococcus Scand J Infect Dis 34 2002 468 471
64. S.C. Natoli, N. Fimiani, and L. Faglieri Toxic shock syndrome due to group C streptococci Intensive care Med 22 1996 985 989
65. D.L. Stevens, M.H. Tanner, and J. Winship Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A N Engl J Med 321 1989 1 7
66. D.L. Stevens Invasive group A streptococcus infections Clin Infect Dis 14 1992 2 13
67. J.C. Rondstrom, M. Hoflig, and C. Lundberg RondstromStreptococcal toxic shock syndrome in a postpartum woman Infection 21 1996 164 167
68. W. Schummer, and C. Schummer Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome Infect Dis Obstet Gynecol 10 2000 217 222
69. M. Rhomberg, F. Furtmüller, and D. Haidinger Streptococcal toxic shock-like syndrome with necrotizing myositis Chirurg 71 2000 844 847
70. P.C. Karakousis, K.R. Page, and M.A. Varello Waterhouse-Friderichsen syndrome after infection with group A streptococcus Mayo Clin Proc 76 2001 1167 1170
71. J. Zimbelman, A. Palmer, and J. Todd Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptyococcus pyogenes infection Pediatr Infect Dis J 18 1999 1096 1100
72. E.M. Mascini, M. Jansze, and L.M. Schouls Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxin A and B by group A streptococci Int J Antimicrob Agents 18 2001 395 398
73. J. Darenberg, B. Soderquist, B.H. Normark, and A. Norrby-Teglund Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for the therapy of toxic shock syndrome Clin Infect Dis 38 2004 836 842
74. R. Kaul, A. Mc Geer, and D.E. Low Intravenous immunoglobulin (IVIG) therapy in streptococcal toxic shock syndrome (STSS): results of a matched case-control study Am J Med 103 1997 18 24
75. H. Irmak, T. Buzgan, and M.K. Karahocagil Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases Acta Med Okayama 57 2003 235 240
76. G. Sternbach The history of anthrax J Emerg Med 23 2003 463 467
77. J.C. Barlett, T.V. Inglesby, and l. Borio Management of anthrax Clin Infect Dis 35 2002 851 858
78. N.S. Duesby, C.P. Webb, and S.H. Leppa Proteolytic inactivation of MAP-kinase-kinase by cutaneous anthrax lethal factor Science 280 1998 734 737
79. J. O'Brien, A. Friedlander, and T. Drier Effects of anthrax toxin components of human neutrophils Infect Immun 47 1985 306 310
80. J.E. Kirby Anthrax lethal toxin induces human endothelial cell apoptosis Infect Immun 72 2004 430 439
81. S. Oncu, and S. Sakarya Anthrax-an overview Med Sci Monit 9 2003 267 283
82. D.P. Lew Bacillus anthracis (Anthrax) G.L. Mandell.J.E Bennett R. Dolin Principles and Practice of Infectious Diseases 5th ed. 2000 Churchchill Livingstone New York 2215 2220
83. A. Kadanali, M. Tasyaran, and S. Kadanali Anthrax during pregnancy: case report and review Clin Infect Dis 36 2003 1343 1346
84. J.D. Grabenstein Anthrax vaccine: a review Immunol Allergy North Am 23 2003 713 730